Amanda Rogers
About Amanda Rogers
Amanda Rogers is the Associate Scientific Director at Bristol Myers Squibb in the United States, with over 13 years of experience in the pharmaceutical industry focusing on process development and engineering.
Title
Amanda Rogers holds the title of Associate Scientific Director at Bristol Myers Squibb in the United States.
Current and Previous Roles at Bristol Myers Squibb
Amanda Rogers has amassed significant experience at Bristol Myers Squibb, where she currently serves as an Associate Scientific Director. Prior to this, she was a Senior Research Investigator from 2016 to 2021 and a Research Investigator II from 2015 to 2016 in the Greater New York City Area. Early in her career, she worked as a Process Development Engineer from 2008 to 2012 and held internships in development engineering and general roles in 2007 for three months each at the Princeton, New Jersey location.
Educational Background
Amanda Rogers has an extensive educational background in Chemical Engineering. She earned her Doctor of Philosophy (PhD) from Rutgers University-New Brunswick from 2012 to 2015. Prior to that, she studied Chemical Engineering at Abertay University in 2005 and achieved a Bachelor of Engineering (BE) from Stevens Institute of Technology, where she studied from 2004 to 2008.
Expertise in Chemical Engineering
With over 13 years in the pharmaceutical industry, Amanda Rogers specializes in chemical engineering and process development. She has led multidisciplinary teams in developing and scaling up novel pharmaceutical processes. Her expertise extends to advanced software tools such as Matlab, GAMS, gProms, Python, DynoChem, Simulink, Aspen Engineering Suite, and Symyx Electronic Notebook. Additionally, she is skilled in laboratory techniques including organic synthesis, solid phase peptide synthesis, HPLC, GC, FTIR, and FBRM.
Experience at Rutgers University
Amanda Rogers served as a PhD Candidate in Chemical Engineering at Rutgers University from 2012 to 2014. During her tenure, she developed data-based and reduced-order models to optimize chemical processes and authored multiple GMP documentation reviews for technology transfer projects.